Latest Breaking News On - Jacinto blas mantaring - Page 1 : comparemela.com

2 solons to distribute ivermectin; FDA says doctors must be present, prescribe it

2 solons to distribute ivermectin; FDA says doctors must be present, prescribe it
gmanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gmanetwork.com Daily Mail and Mail on Sunday newspapers.

United kingdomRodante marcoletaMatandang balara hallVicentey belizario jrMike defensorEric domingoTess lawrieRodrigo duterteJacinto blas mantaringMedicine consultancy ltdWorld health organizationDrug administrationPhilippine college of medicineDepartment of clinical epidemiology the universityDepartment of healthDepartment of science

Philippines to conduct clinical trials for ivermectin as COVID-19 treatment

Philippines to conduct clinical trials for ivermectin as COVID-19 treatment
gmanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gmanetwork.com Daily Mail and Mail on Sunday newspapers.

De la pePhilippines generalUnited statesThe philippinesRodrigo duterteTess lawrieJacinto blas mantaringAileen wangMedicine consultancy ltdDrug administrationTechnological institute of the philippinesDon bosco technical collegeAmerican academy of scienceDepartment of clinical epidemiology the universityBenjamin coPhilippines college of medicine

Solons want probe into DOH, FDA policies on registration, use of COVID-19 drugs

By ANNA FELICIA BAJO, GMA News Published April 15, 2021 5:33pm House Speaker Lord Allan Velasco and Deputy Speaker Bernadette Herrera-Dy have filed a resolution seeking an inquiry into the policies of the Department of Health and the Food and Drug Administration on the registration, utilization and manufacture and distribution of drugs for COVID-19. Through House Resolution 1711, the two lawmakers urged the Committee on Good Government and Public Accountability to conduct an inquiry on the matter as well as the policies and guidelines of both agencies, which appear to be detrimental to public interest amid the pandemic. The resolution specifically mentioned FDA Circular No. 2020-12 or the Guidelines for the Registration of Drug Products under Emergency Use for the Coronavirus Disease 2019.

United kingdomBernadette herrera dyVicentey belizario jrTess lawrieJacinto blas mantaringAllan velascoMedicine consultancy ltdWorld health organizationDrug administrationPhilippine college of medicineDepartment of clinical epidemiology the universityDepartment of healthCollege of public healthEuropean medicines agencyCommittee on good governmentHouse speaker lord allan velasco

Clinical studies needed to assess ivermectin as COVID-19 treatment —pharma group

By HANA BORDEY, GMA News Published April 14, 2021 7:31pm Clinical trials are needed to assess the benefits and risks of anti-parasitic drug ivermectin as a treatment for COVID-19 and to uphold regulatory standards in the pharmaceutical industry, a group of pharmacists said. In a statement sent to GMA News Online, the Philippine Association of Pharmacists in the Pharmaceutical Industry (PAPPI) said they adhere to pertinent laws and regulations in the Philippines to ensure that its member-companies are providing safe and effective medicines to Filipinos. “Some of our member companies continue to carefully examine the results of all available and ongoing clinical studies on the use of ivermectin for the treatment of COVID-19,” PAPPI said.

United kingdomVicentey belizario jrTess lawrieJacinto blas mantaringMedicine consultancy ltdHealthcare association of the philippinesWorld health organizationDrug administrationPhilippine college of medicineDepartment of clinical epidemiology the universityPhilippine association of pharmacistsCollege of public healthEuropean medicines agencyPhilippine associationPharmaceutical industryHealthcare association

Doctors continue ivermectin for COVID-19 debate

Published April 11, 2021 3:48pm Doctors on Friday continued to debate the merits of ivermectin in a fireside chat organized by the Philippine-American Academy of Science and Engineering. During the Zoom session, Dr. Tess Lawrie of The Evidence-Based Medicine Consultancy Ltd. presented her analysis of studies that looked into the use of ivermectin as a COVID-19 treatment. Citing her meta-analysis, there were few serious adverse events (SAEs) recorded during ivermectin use during these studies. Citing data from VigiAccess, an international database of adverse events, Lawrie noted that only 16 deaths have been reported involving ivermectin, compared to much higher totals for remdesivir, which is used to treat COVID-19 symptoms, as well as COVID-19 vaccines.

United statesBenigno agbayaniEric domingoVicentey belizario jrTess lawrieJacinto blas mantaringRafael castilloMedicine consultancy ltdDean of the universityWorld health organizationDrug administrationAmerican academy of scienceDepartment of clinical epidemiology the universityBenjamin coPhilippines college of medicineEuropean medicine agency